搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
来自MSN
8 小时
泰恩康:Semaglutide 司美格鲁肽原液(API)已完成三批生产和检验,第 ...
每经AI快讯,有投资者在投资者互动平台提问:公司司美格鲁肽项目目前进展怎么样? 泰恩康(301263.SZ)10月15日在投资者互动平台表示,Semaglutide 司美格鲁肽原液(API)已完成三批生产和检验,第一批产品已出货 (记者 蔡鼎) ...
7 小时
泰恩康:Semaglutide司美格鲁肽原液第一批产品已出货
e公司讯, 泰恩康 (301263)10月15日在互动平台表示,Semaglutide司美格鲁肽原液(API)已完成三批生产和检验,第一批产品已出货。
News Medical on MSN
14 小时
Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and ...
Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...
Medscape
3 小时
Type 2 Diabetes: Insulin-Free for 24 Months After Novel Endoscopic Procedure
Participants with type 2 diabetes who stopped insulin after receiving the novel ReCET endoscopic procedure in combination ...
Endocrinology Advisor
4 小时
Semaglutide Use Linked to Lower Opioid Overdose Risk in Type 2 Diabetes
Semaglutide use was associated with a lower risk for opioid overdose than other antidiabetic medications in comorbid type 2 diabetes and OUD.
News Medical on MSN
14 小时
Semaglutide improves heart health and reduces weight in obese patients, but with side effects
By Dr. Liji Thomas, MD Study shows that semaglutide not only aids in weight loss but also slashes heart failure risk by 76% ...
FierceBiotech
1 小时
Chinese insulin maker says its GLP-1 beat Ozempic at lowering blood sugar, body weight in ...
Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...
19 小时
WeightWatchers Launches $129 Ozempic Alternative Amid Shortages
In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...
1 天
Truist维持对HIMS的持有评级,FDA审查进展引关注
Truist Securities维持对Hims & Hers Health, Inc. (NYSE:HIMS)的持有评级,目标价保持在$23.00。该公司分析师引用了美国食品和药物管理局(FDA)最近决定重新审视Tirzepatide短缺问题,并继续授权复合药房生产其复合版本,认为这对公司前景有利。 这一决定对Hims & Hers的复合GLP-1产品尤为相关,该产品使用的Semaglutide ...
3 天
8 Reasons You May Still Be Hungry on Semaglutide
Semaglutide — the active ingredient in Ozempic®, Wegovy®, and Rybelsus® — can reduce your appetite and curb food cravings to ...
7 天
Compounded Semaglutide: Is It Safe and Effective?
Compounded semaglutide is semaglutide with an altered formula to create an unbranded alternative to Wegovy and Ozempic.
1 天
on MSN
You can now dress up as a ‘sexy Ozempic shot’ this Halloween
An online store has jumped on the Ozempic craze by releasing a “sexy” semaglutide injection costume just in time for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈